FDMT vs LI · rev $37.0K vs P/E 24, rev $16.06B
4D Molecular Therapeutics Inc (FDMT) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
FDMT currently screens at market cap $518.1M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the FDMT and LI stock pages for the full models.
Not investment advice.